Study summary · 2025 · Evidence review
Heart-failure RPM: outcomes and program components
Pooled results favored first heart-failure hospitalization and mortality, but not all-cause hospitalization.
Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence
Original publication
Ignace L J De Lathauwer; Wessel W Nieuwenhuys; Frederique Hafkamp; Marta Regis; Rutger W M Brouwers; Mathias Funk; Hareld M C Kemps
Máxima Medical Centre; Eindhoven University of Technology; Nederlands Hart Netwerk; Eindhoven MedTech Innovation Center, Netherlands
European Journal of Heart Failure · Online: · Issue: September 2025
Journal version of record. · Full text consulted.
What was studied
- Design
- Evidence review
- Population
- Adults with heart failure
- Sample
- 41 randomized studies; 16,312 participants
- Intervention
- Non-invasive RPM with varied communication and support
- Comparator
- Usual care
- Follow-up
- Mean approximately 9.9 months
- Review search cutoff
- 2023-06
- Setting
- Multiple countries
Methods
Random-effects meta-analysis, including comparisons between program components.
Findings
Odds ratios were 0.78 (95% CI 0.70–0.87) for first HF hospitalization and 0.81 (0.69–0.95) for mortality. All-cause hospitalization was inconclusive: OR 0.90 (0.78–1.05; I²=70%).
Limitations
Interventions varied. Component comparisons did not randomize education, self-management or video independently; they cannot prove component causality.
What this means for care delivery
Use this synthesis to inform care-team design, while retaining null individual trials and avoiding guaranteed outcome claims.